[1]
2017. METASTATIC COLORECTAL CANCER MCRC WITH WILD-TYPE RAS: THE CONTINUATION OF ANTI-EGFR THERAPY WITH A CHANGE OF CHEMOTHERAPY AFTER DISEASE PROGRESSION. Voprosy onkologii. 63, 3 (Mar. 2017), 456–460. DOI:https://doi.org/10.37469/0507-3758-2017-63-3-456-460.